biztrac. BETA
COMPANY REGISTER PROFILE
883053052 ORG. NO. 2025 ACCOUNTS 9 SECTIONS
Active UPDATED 03.10.2026
Other health services

ENDOTELIN AS

Org. no. 883053052 Limited company (AS) Stavanger Incorporated 2001 Active
Ownership graph ↗
Revenue 2025 NOK 22.2m
Operating profit NOK 12.1m
Equity NOK 100,000
Incorporated 2001
Employees 11
Share capital NOK 100,000

ENDOTELIN AS is registered as a limited company in Stavanger, Rogaland with organisation number 883053052. The business is classified under other health services (NACE 86.993). The company was incorporated in 2001 and has 11 registered employees. Registered share capital is NOK 100,000, divided into 1000 shares. The company's stated purpose is: “Tjenester innen helse, samt investeringer i fast eiendom og finansaktiva, og alt som herved er naturlig forbundet.”. The most recent filed accounts, for the 2025 financial year, show NOK 22.2m in revenue and NOK 12.1m in operating profit.

Key figures · 2025

Revenue
NOK 22.2m
▲ +3 %
Operating profit
NOK 12.1m
▼ −4 %
Equity
NOK 100,000
▼ −99 %
Est. value
NOK 37.7m

Financial health · 2025

Liquidity
0.98
Weak
Current assets ÷ current liabilities
Profitability
45.0%
Very good
Return on total assets
Solidity
0.3%
Not satisfactory
Equity as a share of total capital

Who owns ENDOTELIN AS?

ENDOTELIN AS
NOK 22.2m rev. · NOK 12.1m profit

ENDOTELIN AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about ENDOTELIN AS

Who owns ENDOTELIN AS?

FINSNES INVEST AS is the largest registered owner, with 100.0%.

What is the revenue of ENDOTELIN AS?

ENDOTELIN AS had revenue of NOK 22.2m in 2025.

Who is the general manager of ENDOTELIN AS?

Finn Finsnes is registered as general manager of ENDOTELIN AS.

Where is ENDOTELIN AS based?

ENDOTELIN AS has its business address in Stavanger.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.